Nuvalent, Inc.
NUVL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.25 | -1.08 | 0.80 | -0.04 |
| FCF Yield | -3.56% | -2.33% | -4.39% | -9.64% |
| EV / EBITDA | 0.00 | -31.29 | -14.37 | -7.56 |
| Quality | ||||
| ROIC | -25.85% | -21.34% | -18.60% | -16.07% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.71 | 0.79 | 0.79 | 0.86 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -85.55% | -53.51% | -62.43% | -167.58% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 2.66 | 2.81 | 1.50 |
| Interest Coverage | 0.00 | -6.42 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |